Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-12-001354
Filing Date
2012-05-08
Accepted
2012-05-08 16:29:09
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1211424.htm 10-Q 893999
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10484
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10640
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5582
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5618
  Complete submission text file 0001178913-12-001354.txt   3390452

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT psti-20120331.xml EX-101.INS 487452
7 TAXONOMY EXTENSION SCHEMA psti-20120331.xsd EX-101.SCH 21328
8 TAXONOMY EXTENSION CALCULATION LINKBASE psti-20120331_cal.xml EX-101.CAL 49578
9 TAXONOMY EXTENSION LABEL LINKBASE psti-20120331_lab.xml EX-101.LAB 288915
10 TAXONOMY EXTENSION PRESENTATION LINKBASE psti-20120331_pre.xml EX-101.PRE 107518
11 TAXONOMY EXTENSION DEFINITION LINKBASE psti-20120331_def.xml EX-101.DEF 16461
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 12821789
SIC: 2836 Biological Products, (No Diagnostic Substances)